Prostaglandin E receptors as targets for ischemic stroke: Novel evidence and molecular mechanisms of efficacy L Li, MN Sluter, Y Yu, J Jiang Pharmacological research 163, 105238, 2021 | 26 | 2021 |
Neuroinflammatory mediators in acquired epilepsy: an update Y Chen, MM Nagib, N Yasmen, MN Sluter, TL Littlejohn, Y Yu, J Jiang Inflammation Research 72 (4), 683-701, 2023 | 24 | 2023 |
EP2 antagonists (2011–2021): a decade’s journey from discovery to therapeutics MN Sluter, R Hou, L Li, N Yasmen, Y Yu, J Liu, J Jiang Journal of medicinal chemistry 64 (16), 11816-11836, 2021 | 23 | 2021 |
Ablation of Siglec-E augments brain inflammation and ischemic injury L Li, Y Chen, MN Sluter, R Hou, J Hao, Y Wu, GY Chen, Y Yu, J Jiang Journal of neuroinflammation 19 (1), 191, 2022 | 10 | 2022 |
Ganaxolone for management of seizures associated with CDKL5 deficiency disorder N Yasmen, MN Sluter, Y Yu, J Jiang Trends in Pharmacological Sciences, 2023 | 8 | 2023 |
Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma R Hou, Y Yu, MN Sluter, L Li, J Hao, J Fang, J Yang, J Jiang Cell reports 39 (12), 2022 | 8 | 2022 |
Transient inhibition of microsomal prostaglandin E synthase-1 after status epilepticus blunts brain inflammation and is neuroprotective N Yasmen, MN Sluter, L Li, Y Yu, J Jiang Molecular Brain 16 (1), 14, 2023 | 6 | 2023 |
Prostaglandin receptor EP2 is a novel molecular target for high-risk neuroblastoma R Hou, Y Yu, DT Nguyen, MN Sluter, L Li, J Yang, J Jiang BioRxiv, 2020.02. 24.963108, 2020 | 3 | 2020 |
Novel, brain-permeable, cross-species benzothiazole inhibitors of microsomal prostaglandin E synthase-1 (MPGES-1) dampen neuroinflammation in vitro and in vivo MN Sluter, R Bhuniya, X Yuan, A Ramaraju, Y Chen, Y Yu, KR Parmar, ... ACS Pharmacology & Translational Science 6 (4), 587-599, 2023 | 1 | 2023 |
The inducible prostaglandin E synthase (mPGES-1) in neuroinflammatory disorders MN Sluter, Q Li, N Yasmen, Y Chen, L Li, R Hou, Y Yu, CY Yang, ... Experimental Biology and Medicine 248 (9), 811-819, 2023 | | 2023 |
Development of Novel, Brain Permeable, mPGES-1 Inhibitors for Inflammatory Conditions M Sluter | | 2023 |